Oncology and VTE

Cancer patients are at a significantly greater risk for developing a blood clot (PE or DVT) compared with patients without cancer. VTE is the second most common cause of death in ambulatory cancer patients (tied with infections).

In recognition of the prophylaxis and treatment gap occurring in Canadian oncology patients, a group of 40 Canadian experts developed shared care guidelines and algorithms to help guide VTE prophylaxis and treatment in oncology outpatients.

Shared Care Guidelines:


Copyright 2018 VTE Simplified.   Disclaimer and Privacy Policy   Grant in aid from Leo Pharma Inc.

Back to Top